{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:43:03Z","timestamp":1773283383056,"version":"3.50.1"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,11,27]],"date-time":"2014-11-27T00:00:00Z","timestamp":1417046400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s12879-014-0622-0","type":"journal-article","created":{"date-parts":[[2014,11,26]],"date-time":"2014-11-26T20:06:21Z","timestamp":1417032381000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Antimicrobial susceptibility of Neisseria gonorrhoeaeisolates from symptomatic men attending the Nanjing sexually transmitted diseases clinic (2011\u20132012): genetic characteristics of isolates with reduced sensitivity to ceftriaxone"],"prefix":"10.1186","volume":"14","author":[{"given":"Sai","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Hong","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Jing","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fa-Xing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao-Xi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A","family":"Rice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,27]]},"reference":[{"key":"622_CR1","unstructured":"National Health and Family Planning Commision of the People\u2019s Republic of China: 2013 Annual National Report Of Notifiable Infectious Diseases [], [http:\/\/www.nhfpc.gov.cn\/jkj\/s3578\/201404\/f81a87a2fe3f453a99677a7d9d89de0c]"},{"key":"622_CR2","unstructured":"Global action Plan to Control the Spread and Impact of Antimicrobial Resistance in Neisseria Gonorrhoeae. 2012, WHO Press, Geneva"},{"key":"622_CR3","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1586\/14787210.4.4.619","volume":"4","author":"J Tapsall","year":"2006","unstructured":"Tapsall J: Antibiotic resistance in Neisseria gonorrhoeae is diminishing available treatment options for gonorrhea: some possible remedies. Expert Rev Anti Infect Ther. 2006, 4: 619-628. 10.1586\/14787210.4.4.619.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"622_CR4","doi-asserted-by":"publisher","first-page":"E19","DOI":"10.1111\/j.1749-6632.2011.06215.x","volume":"1230","author":"M Unemo","year":"2011","unstructured":"Unemo M, Shafer WM: Antibiotic resistance in Neisseria gonorrhoeae: origin, evolution, and lessons learned for the future. Ann N Y Acad Sci. 2011, 1230: E19-E28. 10.1111\/j.1749-6632.2011.06215.x.","journal-title":"Ann N Y Acad Sci"},{"key":"622_CR5","doi-asserted-by":"crossref","unstructured":"Ison CA, Hussey J, Sankar KN, Evans J, Alexander S: Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010. Euro Surveill 2011, 16(14).,","DOI":"10.2807\/ese.16.14.19833-en"},{"key":"622_CR6","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.2217\/fmb.12.117","volume":"7","author":"M Unemo","year":"2012","unstructured":"Unemo M, Nicholas RA: Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea. Future Microbiol. 2012, 7: 1401-1422. 10.2217\/fmb.12.117.","journal-title":"Future Microbiol"},{"key":"622_CR7","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1517\/14656560902731993","volume":"10","author":"PM Barry","year":"2009","unstructured":"Barry PM, Klausner JD: The use of cephalosporins for gonorrhea: the impending problem of resistance. Expert Opin Pharmacother. 2009, 10: 555-577. 10.1517\/14656560902731993.","journal-title":"Expert Opin Pharmacother"},{"key":"622_CR8","doi-asserted-by":"crossref","unstructured":"Unemo M, Golparian D, Syversen G, Vestrheim DF, Moi H: Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010. Euro Surveill 2010, 15(47).,","DOI":"10.2807\/ese.15.47.19721-en"},{"key":"622_CR9","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1128\/AAC.00325-11","volume":"55","author":"M Ohnishi","year":"2011","unstructured":"Ohnishi M, Golparian D, Shimuta K, Saika T, Hoshina S, Iwasaku K, Nakayama S, Kitawaki J, Unemo M: Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother. 2011, 55: 3538-3545. 10.1128\/AAC.00325-11.","journal-title":"Antimicrob Agents Chemother"},{"key":"622_CR10","doi-asserted-by":"crossref","unstructured":"Unemo M, Golparian D, Potocnik M, Jeverica S: Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011. Euro Surveill 2012, 17(25).,","DOI":"10.2807\/ese.17.25.20200-en"},{"key":"622_CR11","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1099\/jmm.0.007641-0","volume":"58","author":"J Tapsall","year":"2009","unstructured":"Tapsall J, Read P, Carmody C, Bourne C, Ray S, Limnios A, Sloots T, Whiley D: Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods. J Med Microbiol. 2009, 58: 683-687. 10.1099\/jmm.0.007641-0.","journal-title":"J Med Microbiol"},{"key":"622_CR12","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1128\/AAC.49.1.137-143.2005","volume":"49","author":"M Ito","year":"2005","unstructured":"Ito M, Deguchi T, Mizutani KS, Yasuda M, Yokoi S, Ito S, Takahashi Y, Ishihara S, Kawamura Y, Ezaki T: Emergence and spread of Neisseria gonorrhoeae clinical isolates harboring mosaic-like structure of penicillin-binding protein 2 in Central Japan. Antimicrob Agents Chemother. 2005, 49: 137-143. 10.1128\/AAC.49.1.137-143.2005.","journal-title":"Antimicrob Agents Chemother"},{"key":"622_CR13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10156-008-0610-7","volume":"14","author":"K Osaka","year":"2008","unstructured":"Osaka K, Takakura T, Narukawa K, Takahata M, Endo K, Kiyota H, Onodera S: Analysis of amino acid sequences of penicillin-binding protein 2 in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime and ceftriaxone. J Infect Chemother. 2008, 14: 195-203. 10.1007\/s10156-008-0610-7.","journal-title":"J Infect Chemother"},{"key":"622_CR14","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1074\/jbc.M805761200","volume":"284","author":"AJ Powell","year":"2009","unstructured":"Powell AJ, Tomberg J, Deacon AM, Nicholas RA, Davies C: Crystal structures of penicillin-binding protein 2 from penicillin-susceptible and -resistant strains of Neisseria gonorrhoeae reveal an unexpectedly subtle mechanism for antibiotic resistance. J Biol Chem. 2009, 284: 1202-1212. 10.1074\/jbc.M805761200.","journal-title":"J Biol Chem"},{"key":"622_CR15","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.1128\/AAC.00306-07","volume":"51","author":"DM Whiley","year":"2007","unstructured":"Whiley DM, Limnios EA, Ray S, Sloots TP, Tapsall JW: Diversity of penA alterations and subtypes in Neisseria gonorrhoeae strains from Sydney, Australia, that are less susceptible to ceftriaxone. Antimicrob Agents Chemother. 2007, 51: 3111-3116. 10.1128\/AAC.00306-07.","journal-title":"Antimicrob Agents Chemother"},{"key":"622_CR16","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1093\/jac\/dkq187","volume":"65","author":"DM Whiley","year":"2010","unstructured":"Whiley DM, Goire N, Lambert SB, Ray S, Limnios EA, Nissen MD, Sloots TP, Tapsall JW: Reduced susceptibility to ceftriaxone in Neisseria gonorrhoeae is associated with mutations G542S, P551S and P551L in the gonococcal penicillin-binding protein 2. J Antimicrob Chemother. 2010, 65: 1615-1618. 10.1093\/jac\/dkq187.","journal-title":"J Antimicrob Chemother"},{"key":"622_CR17","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/j.1365-2958.2008.06424.x","volume":"70","author":"DM Warner","year":"2008","unstructured":"Warner DM, Shafer WM, Jerse AE: Clinically relevant mutations that cause derepression of the Neisseria gonorrhoeae MtrC-MtrD-MtrE Efflux pump system confer different levels of antimicrobial resistance and in vivo fitness. Mol Microbiol. 2008, 70: 462-478. 10.1111\/j.1365-2958.2008.06424.x.","journal-title":"Mol Microbiol"},{"issue":"Pt 3","key":"622_CR18","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1099\/13500872-141-3-611","volume":"141","author":"KE Hagman","year":"1995","unstructured":"Hagman KE, Pan W, Spratt BG, Balthazar JT, Judd RC, Shafer WM: Resistance of Neisseria gonorrhoeae to antimicrobial hydrophobic agents is modulated by the mtrRCDE efflux system. Microbiology. 1995, 141 (Pt 3): 611-622. 10.1099\/13500872-141-3-611.","journal-title":"Microbiology"},{"key":"622_CR19","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1128\/AAC.42.11.2799","volume":"42","author":"MJ Gill","year":"1998","unstructured":"Gill MJ, Simjee S, Al-Hattawi K, Robertson BD, Easmon CS, Ison CA: Gonococcal resistance to beta-lactams and tetracycline involves mutation in loop 3 of the porin encoded at the penB locus. Antimicrob Agents Chemother. 1998, 42: 2799-2803.","journal-title":"Antimicrob Agents Chemother"},{"key":"622_CR20","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1128\/AAC.46.3.769-777.2002","volume":"46","author":"PA Ropp","year":"2002","unstructured":"Ropp PA, Hu M, Olesky M, Nicholas RA: Mutations in ponA, the gene encoding penicillin-binding protein 1, and a novel locus, penC, are required for high-level chromosomally mediated penicillin resistance in Neisseria gonorrhoeae. Antimicrob Agents Chemother. 2002, 46: 769-777. 10.1128\/AAC.46.3.769-777.2002.","journal-title":"Antimicrob Agents Chemother"},{"key":"622_CR21","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1111\/j.1365-2958.2005.04752.x","volume":"57","author":"S Zhao","year":"2005","unstructured":"Zhao S, Tobiason DM, Hu M, Seifert HS, Nicholas RA: The penC mutation conferring antibiotic resistance in Neisseria gonorrhoeae arises from a mutation in the PilQ secretin that interferes with multimer stability. Mol Microbiol. 2005, 57: 1238-1251. 10.1111\/j.1365-2958.2005.04752.x.","journal-title":"Mol Microbiol"},{"key":"622_CR22","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1093\/jac\/dkq377","volume":"65","author":"DM Whiley","year":"2010","unstructured":"Whiley DM, Jacobsson S, Tapsall JW, Nissen MD, Sloots TP, Unemo M: Alterations of the pilQ gene in Neisseria gonorrhoeae are unlikely contributors to decreased susceptibility to ceftriaxone and cefixime in clinical gonococcal strains. J Antimicrob Chemother. 2010, 65: 2543-2547. 10.1093\/jac\/dkq377.","journal-title":"J Antimicrob Chemother"},{"key":"622_CR23","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1128\/AAC.00304-09","volume":"53","author":"S Zhao","year":"2009","unstructured":"Zhao S, Duncan M, Tomberg J, Davies C, Unemo M, Nicholas RA: Genetics of chromosomally mediated intermediate resistance to ceftriaxone and cefixime in Neisseria gonorrhoeae. Antimicrob Agents Chemother. 2009, 53: 3744-3751. 10.1128\/AAC.00304-09.","journal-title":"Antimicrob Agents Chemother"},{"key":"622_CR24","unstructured":"Centers for Disease Control and Prevention (CDC): Cephalosporin-Resistant Neisseria Gonorrhoeae Public Health Response Plan. CDC 2012 [], [http:\/\/www.cdc.gov\/std\/treatment\/Ceph-R-ResponsePlanJuly30-2012.pdf]"},{"key":"622_CR25","unstructured":"Response Plan to Control and Manage the Threat of Multidrug-Resistant Gonorrhoea in Europe. 2012, ECDC, Stockholm"},{"key":"622_CR26","unstructured":"National Center for STD Control, China CDC: Brief report of Chinese Gonococcal Surveillance. [], [http:\/\/www.ncstdc.org\/show.asp?id=967]"},{"key":"622_CR27","unstructured":"Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific and South East Asian Regions, 2009. Commun Dis Intell Q Rep. 2011, 35: 2-7."},{"key":"622_CR28","first-page":"95","volume":"36","author":"MM Lahra","year":"2012","unstructured":"Lahra MM: Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific and South East Asian Regions, 2010. Commun Dis Intell Q Rep. 2012, 36: 95-100.","journal-title":"Commun Dis Intell Q Rep"},{"key":"622_CR29","doi-asserted-by":"crossref","unstructured":"Surveillance of antibiotic susceptibility of Neisseria gonorrhoeae in the WHO western Pacific region 1992\u20134. Genitourin Med. 1997, 73: 355-361.","DOI":"10.1136\/sti.73.5.355"},{"key":"622_CR30","unstructured":"Gonorrhea. Guidelines for Diagnosis and Treatment of Sexually Transmitted Diseases [in Chinese]. Edited by: Wang QQ, Zhang GC. 2007, Shanghai Scientific and Technological Literature Press, Shanghai"},{"issue":"4","key":"622_CR31","doi-asserted-by":"publisher","first-page":"iv28","DOI":"10.1136\/sextrans-2012-050904","volume":"89","author":"M Bala","year":"2013","unstructured":"Bala M, Kakran M, Singh V, Sood S, Ramesh V: Monitoring antimicrobial resistance in Neisseria gonorrhoeae in selected countries of the WHO South-East Asia Region between 2009 and 2012: a retrospective analysis. Sex Transm Infect. 2013, 89 (4): iv28-iv35. 10.1136\/sextrans-2012-050904.","journal-title":"Sex Transm Infect"},{"key":"622_CR32","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/S1473-3099(13)70143-9","volume":"13","author":"CA Ison","year":"2013","unstructured":"Ison CA, Town K, Obi C, Chisholm S, Hughes G, Livermore DM, Lowndes CM: Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007\u20132011. Lancet Infect Dis. 2013, 13: 762-768. 10.1016\/S1473-3099(13)70143-9.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"622_CR33","doi-asserted-by":"publisher","first-page":"iv5","DOI":"10.1136\/sextrans-2013-051162","volume":"89","author":"RD Kirkcaldy","year":"2013","unstructured":"Kirkcaldy RD, Kidd S, Weinstock HS, Papp JR, Bolan GA: Trends in antimicrobial resistance in Neisseria gonorrhoeae in the USA: the Gonococcal Isolate Surveillance Project (GISP), January 2006-June 2012. Sex Transm Infect. 2013, 89 (4): iv5-iv10. 10.1136\/sextrans-2013-051162.","journal-title":"Sex Transm Infect"},{"key":"622_CR34","unstructured":"Antimicrobial Resistance Global Report on Surveillance: 2014 Summary. 2014, WHO Press, Geneva"},{"key":"622_CR35","volume-title":"Antimicrobial Resistance in Neisseria Gonorrhoeae","author":"J Tapsall","year":"2001","unstructured":"Tapsall J: Antimicrobial Resistance in Neisseria Gonorrhoeae. 2001, WHO Press, Geneva"},{"key":"622_CR36","first-page":"422","volume":"72","author":"J Sherrard","year":"1996","unstructured":"Sherrard J, Barlow D: Gonorrhoea in men: clinical and diagnostic aspects. Genitourin Med. 1996, 72: 422-426.","journal-title":"Genitourin Med"},{"key":"622_CR37","unstructured":"Neisseria gonorrhoeae. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement. CLSI document M100-S22. 2012, Clinical and Laboratory Standards Institute, Wayne, PA, 100-102."},{"key":"622_CR38","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1093\/jac\/dks162","volume":"67","author":"J Camara","year":"2012","unstructured":"Camara J, Serra J, Ayats J, Bastida T, Carnicer-Pont D, Andreu A, Ardanuy C: Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain. J Antimicrob Chemother. 2012, 67: 1858-1860. 10.1093\/jac\/dks162.","journal-title":"J Antimicrob Chemother"},{"key":"622_CR39","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1097\/OLQ.0b013e3180ca8f24","volume":"34","author":"X Su","year":"2007","unstructured":"Su X, Jiang F, Dai X, Sun H, Ye S: Surveillance of antimicrobial susceptibilities in Neisseria gonorrhoeae in Nanjing, China, 1999\u20132006. Sex Transm Dis. 2007, 34: 995-999.","journal-title":"Sex Transm Dis"},{"key":"622_CR40","first-page":"141","volume":"57","author":"EH Sng","year":"1981","unstructured":"Sng EH, Yeo KL, Rajan VS: Simple method for detecting penicillinase-producing Neisseria gonorrhoeae and Staphylococcus aureus. Br J Vener Dis. 1981, 57: 141-142.","journal-title":"Br J Vener Dis"},{"key":"622_CR41","first-page":"29","volume":"42","author":"RJ Gorwitz","year":"1993","unstructured":"Gorwitz RJ, Nakashima AK, Moran JS, Knapp JS: Sentinel surveillance for antimicrobial resistance in Neisseria gonorrhoeae--United States, 1988\u20131991. The Gonococcal Isolate Surveillance Project Study Group. MMWR CDC Surveill Summ. 1993, 42: 29-39.","journal-title":"MMWR CDC Surveill Summ"},{"key":"622_CR42","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1136\/sti.75.1.60","volume":"75","author":"A Turner","year":"1999","unstructured":"Turner A, Gough KR, Leeming JP: Molecular epidemiology of tetM genes in Neisseria gonorrhoeae. Sex Transm Infect. 1999, 75: 60-66. 10.1136\/sti.75.1.60.","journal-title":"Sex Transm Infect"},{"key":"622_CR43","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/jac\/45.6.777","volume":"45","author":"HM Palmer","year":"2000","unstructured":"Palmer HM, Leeming JP, Turner A: A multiplex polymerase chain reaction to differentiate beta-lactamase plasmids of neisseria gonorrhoeae. J Antimicrob Chemother. 2000, 45: 777-782. 10.1093\/jac\/45.6.777.","journal-title":"J Antimicrob Chemother"},{"key":"622_CR44","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1093\/jac\/dkr021","volume":"66","author":"M Liao","year":"2011","unstructured":"Liao M, Gu WM, Yang Y, Dillon JA: Analysis of mutations in multiple loci of Neisseria gonorrhoeae isolates reveals effects of PIB, PBP2 and MtrR on reduced susceptibility to ceftriaxone. J Antimicrob Chemother. 2011, 66: 1016-1023. 10.1093\/jac\/dkr021.","journal-title":"J Antimicrob Chemother"},{"key":"622_CR45","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/jac\/dkp505","volume":"65","author":"SG Lee","year":"2010","unstructured":"Lee SG, Lee H, Jeong SH, Yong D, Chung GT, Lee YS, Chong Y, Lee K: Various penA mutations together with mtrR, porB and ponA mutations in Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxone. J Antimicrob Chemother. 2010, 65: 669-675. 10.1093\/jac\/dkp505.","journal-title":"J Antimicrob Chemother"},{"key":"622_CR46","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1128\/AAC.01010-09","volume":"54","author":"M Ohnishi","year":"2010","unstructured":"Ohnishi M, Watanabe Y, Ono E, Takahashi C, Oya H, Kuroki T, Shimuta K, Okazaki N, Nakayama S, Watanabe H: Spread of a chromosomal cefixime-resistant penA gene among different Neisseria gonorrhoeae lineages. Antimicrob Agents Chemother. 2010, 54: 1060-1067. 10.1128\/AAC.01010-09.","journal-title":"Antimicrob Agents Chemother"},{"key":"622_CR47","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/OLQ.0b013e3182401b69","volume":"39","author":"I Martin","year":"2012","unstructured":"Martin I, Sawatzky P, Allen V, Hoang L, Lefebvre B, Mina N, Wong T, Gilmour M: Emergence and characterization of Neisseria gonorrhoeae isolates with decreased susceptibilities to ceftriaxone and cefixime in Canada: 2001\u20132010. Sex Transm Dis. 2012, 39: 316-323. 10.1097\/OLQ.0b013e3182401b69.","journal-title":"Sex Transm Dis"},{"key":"622_CR48","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.jfma.2012.03.015","volume":"111","author":"CC Chen","year":"2012","unstructured":"Chen CC, Lin KY, Li SY: The role of penicillin-binding protein 2 (PBP2) in the cephalosporin susceptibility of Neisseria gonorrhoeae and the need for consensus in naming of PBP2. J Formos Med Assoc. 2012, 111: 665-666. 10.1016\/j.jfma.2012.03.015.","journal-title":"J Formos Med Assoc"},{"key":"622_CR49","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1128\/AAC.00788-10","volume":"55","author":"VG Allen","year":"2011","unstructured":"Allen VG, Farrell DJ, Rebbapragada A, Tan J, Tijet N, Perusini SJ, Towns L, Lo S, Low DE, Melano RG: Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada. Antimicrob Agents Chemother. 2011, 55: 703-712. 10.1128\/AAC.00788-10.","journal-title":"Antimicrob Agents Chemother"},{"key":"622_CR50","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1086\/383047","volume":"189","author":"IM Martin","year":"2004","unstructured":"Martin IM, Ison CA, Aanensen DM, Fenton KA, Spratt BG: Rapid sequence-based identification of gonococcal transmission clusters in a large metropolitan area. J Infect Dis. 2004, 189: 1497-1505. 10.1086\/383047.","journal-title":"J Infect Dis"},{"key":"622_CR51","doi-asserted-by":"publisher","first-page":"e00187","DOI":"10.1128\/mBio.00187-11","volume":"2","author":"EA Ohneck","year":"2011","unstructured":"Ohneck EA, Zalucki YM, Johnson PJ, Dhulipala V, Golparian D, Unemo M, Jerse AE, Shafer WM: A novel mechanism of high-level, broad-spectrum antibiotic resistance caused by a single base pair change in Neisseria gonorrhoeae. MBio. 2011, 2: e00187-11. 10.1128\/mBio.00187-11.","journal-title":"MBio"},{"key":"622_CR52","first-page":"1173","volume":"32","author":"Y Yang","year":"2009","unstructured":"Yang Y, WL ZC, Gu W: Study of antimicrobial susceptibilities and molecular resistance determines in Neisseria gonorrhoeae isolated in Shanghai. Chin J Lab Med. 2009, 32: 1173-1175.","journal-title":"Chin J Lab Med"},{"key":"622_CR53","first-page":"345","volume":"20","author":"Y Jiang","year":"2013","unstructured":"Jiang Y, LJ XY, Lin HL, Wang YX: Study on drug resistance of 103 strains of Neisseria gonorrhoeae. Practical Preventive Medicine. 2013, 20: 345-347.","journal-title":"Practical Preventive Medicine"},{"key":"622_CR54","first-page":"56","volume":"27","author":"N Zhong","year":"2013","unstructured":"Zhong N, ZW WF, Zhang LF, Lu YZ: Analysis on the drug-resistance of Nersseria gonorrhoeae to antibiotics in Hainan area from 2006\u20132011. Chin J Derm Venereol. 2013, 27: 56-57.","journal-title":"Chin J Derm Venereol"},{"key":"622_CR55","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1471-2334-13-35","volume":"13","author":"S Sethi","year":"2013","unstructured":"Sethi S, Golparian D, Bala M, Dorji D, Ibrahim M, Jabeen K, Unemo M: Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from India, Pakistan and Bhutan in 2007\u20132011. BMC Infect Dis. 2013, 13: 35-10.1186\/1471-2334-13-35.","journal-title":"BMC Infect Dis"},{"key":"622_CR56","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1471-2334-13-40","volume":"13","author":"B Olsen","year":"2013","unstructured":"Olsen B, Pham TL, Golparian D, Johansson E, Tran HK, Unemo M: Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from Vietnam, 2011. BMC Infect Dis. 2013, 13: 40-10.1186\/1471-2334-13-40.","journal-title":"BMC Infect Dis"},{"key":"622_CR57","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1097\/OLQ.0b013e31822e60a4","volume":"38","author":"H Lee","year":"2011","unstructured":"Lee H, Hong SG, Soe Y, Yong D, Jeong SH, Lee K, Chong Y: Trends in antimicrobial resistance of Neisseria gonorrhoeae isolated from Korean patients from 2000 to 2006. Sex Transm Dis. 2011, 38: 1082-1086. 10.1097\/OLQ.0b013e31822e60a4.","journal-title":"Sex Transm Dis"},{"key":"622_CR58","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1097\/OLQ.0b013e31822c664f","volume":"38","author":"I Martin","year":"2011","unstructured":"Martin I, Jayaraman G, Wong T, Liu G, Gilmour M: Trends in antimicrobial resistance in Neisseria gonorrhoeae isolated in Canada: 2000\u20132009. Sex Transm Dis. 2011, 38: 892-898. 10.1097\/OLQ.0b013e31822c664f.","journal-title":"Sex Transm Dis"},{"issue":"4","key":"622_CR59","doi-asserted-by":"publisher","first-page":"iv36","DOI":"10.1136\/sextrans-2012-050905","volume":"89","author":"JA Dillon","year":"2013","unstructured":"Dillon JA, Trecker MA, Thakur SD: Two decades of the gonococcal antimicrobial surveillance program in South America and the Caribbean: challenges and opportunities. Sex Transm Infect. 2013, 89 (4): iv36-iv41. 10.1136\/sextrans-2012-050905.","journal-title":"Sex Transm Infect"},{"key":"622_CR60","doi-asserted-by":"crossref","unstructured":"Kubanova A, Frigo N, Kubanov A, Sidorenko S, Lesnaya I, Polevshikova S, Solomka V, Bukanov N, Domeika M, Unemo M: The Russian gonococcal antimicrobial susceptibility programme (RU-GASP)--national resistance prevalence in 2007 and 2008, and trends during 2005\u20132008. Euro Surveill 2010, 15(14).,","DOI":"10.2807\/ese.15.14.19533-en"},{"key":"622_CR61","doi-asserted-by":"crossref","unstructured":"Cole MJ, Unemo M, Hoffmann S, Chisholm SA, Ison CA, van de Laar MJ: The European gonococcal antimicrobial surveillance programme, 2009. Euro Surveill 2011, 16(42).,","DOI":"10.2807\/ese.16.42.19995-en"},{"key":"622_CR62","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1136\/sti.2010.044164","volume":"86","author":"MJ Cole","year":"2010","unstructured":"Cole MJ, Chisholm SA, Hoffmann S, Stary A, Lowndes CM, Ison CA: European surveillance of antimicrobial resistance in Neisseria gonorrhoeae. Sex Transm Infect. 2010, 86: 427-432. 10.1136\/sti.2010.044164.","journal-title":"Sex Transm Infect"},{"key":"622_CR63","unstructured":"Gonococcal Antimicrobial Susceptibility Surveillance in Europe 2011. 2013, ECDC, Stockholm"},{"key":"622_CR64","unstructured":"Australian Gonococcal Surveillance Programme annual report, 2010. Commun Dis Intell Q Rep. 2011, 35: 229-236."},{"issue":"4","key":"622_CR65","doi-asserted-by":"publisher","first-page":"iv11","DOI":"10.1136\/sextrans-2012-050907","volume":"89","author":"FJ Ndowa","year":"2013","unstructured":"Ndowa FJ, Francis JM, Machiha A, Faye-Kette H, Fonkoua MC: Gonococcal antimicrobial resistance: perspectives from the African region. Sex Transm Infect. 2013, 89 (4): iv11-iv15. 10.1136\/sextrans-2012-050907.","journal-title":"Sex Transm Infect"},{"key":"622_CR66","doi-asserted-by":"publisher","first-page":"3882","DOI":"10.1128\/AAC.00155-11","volume":"55","author":"SD Mehta","year":"2011","unstructured":"Mehta SD, Maclean I, Ndinya-Achola JO, Moses S, Martin I, Ronald A, Agunda L, Murugu R, Bailey RC, Melendez J, Zenilman JM: Emergence of quinolone resistance and cephalosporin MIC creep in Neisseria gonorrhoeae isolates from a cohort of young men in Kisumu, Kenya, 2002 to 2009. Antimicrob Agents Chemother. 2011, 55: 3882-3888. 10.1128\/AAC.00155-11.","journal-title":"Antimicrob Agents Chemother"},{"key":"622_CR67","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1093\/jac\/dkt034","volume":"68","author":"DA Lewis","year":"2013","unstructured":"Lewis DA, Sriruttan C, Muller EE, Golparian D, Gumede L, Fick D, de Wet J, Maseko V, Coetzee J, Unemo M: Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure. J Antimicrob Chemother. 2013, 68: 1267-1270. 10.1093\/jac\/dkt034.","journal-title":"J Antimicrob Chemother"},{"key":"622_CR68","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1139\/cjm-2013-0357","volume":"59","author":"I Martin","year":"2013","unstructured":"Martin I, Sawatzky P, Liu G, Allen V, Lefebvre B, Hoang L, Lovgren M, Haldane D, Caeseele PV, Horsman G, Garceau R, Ratnam S, Wong T, Gilmour M: Antimicrobial susceptibilities and distribution of sequence types of Neisseria gonorrhoeae isolates in Canada: 2010. Can J Microbiol. 2013, 59: 671-678. 10.1139\/cjm-2013-0357.","journal-title":"Can J Microbiol"},{"key":"622_CR69","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/OLQ.0b013e31827bd64c","volume":"40","author":"TS Hottes","year":"2013","unstructured":"Hottes TS, Lester RT, Hoang LM, McKay R, Imperial M, Gilbert M, Patrick D, Wong T, Martin I, Ogilvie G: Cephalosporin and azithromycin susceptibility in Neisseria gonorrhoeae isolates by site of infection, British Columbia, 2006 to 2011. Sex Transm Dis. 2013, 40: 46-51. 10.1097\/OLQ.0b013e31827bd64c.","journal-title":"Sex Transm Dis"},{"key":"622_CR70","unstructured":"Cephalosporin susceptibility among Neisseria gonorrhoeae isolates--United States, 2000\u20132010. MMWR Morb Mortal Wkly Rep. 2011, 60: 873-877."},{"key":"622_CR71","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1128\/AAC.01775-12","volume":"57","author":"M Unemo","year":"2013","unstructured":"Unemo M, Golparian D, Skogen V, Olsen AO, Moi H, Syversen G, Hjelmevoll SO: Neisseria gonorrhoeae strain with high-level resistance to spectinomycin due to a novel resistance mechanism (mutated ribosomal protein S5) verified in Norway. Antimicrob Agents Chemother. 2013, 57: 1057-1061. 10.1128\/AAC.01775-12.","journal-title":"Antimicrob Agents Chemother"},{"key":"622_CR72","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1056\/NEJM198707303170504","volume":"317","author":"JW Boslego","year":"1987","unstructured":"Boslego JW, Tramont EC, Takafuji ET, Diniega BM, Mitchell BS, Small JW, Khan WN, Stein DC: Effect of spectinomycin use on the prevalence of spectinomycin-resistant and of penicillinase-producing Neisseria gonorrhoeae. N Engl J Med. 1987, 317: 272-278. 10.1056\/NEJM198707303170504.","journal-title":"N Engl J Med"},{"key":"622_CR73","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/S0140-6736(76)92466-1","volume":"2","author":"I Phillips","year":"1976","unstructured":"Phillips I: Beta-lactamase-producing, penicillin-resistant gonococcus. Lancet. 1976, 2: 656-657. 10.1016\/S0140-6736(76)92466-1.","journal-title":"Lancet"},{"issue":"Suppl","key":"622_CR74","doi-asserted-by":"publisher","first-page":"S125","DOI":"10.1128\/CMR.2.Suppl.S125","volume":"2","author":"JA Dillon","year":"1989","unstructured":"Dillon JA, Yeung KH: Beta-lactamase plasmids and chromosomally mediated antibiotic resistance in pathogenic Neisseria species. Clin Microbiol Rev. 1989, 2 (Suppl): S125-S133.","journal-title":"Clin Microbiol Rev"},{"key":"622_CR75","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/OLQ.0b013e3181fc695a","volume":"38","author":"SA Fayemiwo","year":"2011","unstructured":"Fayemiwo SA, Muller EE, Gumede L, Lewis DA: Plasmid-mediated penicillin and tetracycline resistance among Neisseria gonorrhoeae isolates in South Africa: prevalence, detection and typing using a novel molecular assay. Sex Transm Dis. 2011, 38: 329-333.","journal-title":"Sex Transm Dis"},{"key":"622_CR76","doi-asserted-by":"publisher","first-page":"4984","DOI":"10.1128\/AAC.02993-14","volume":"58","author":"E Trembizki","year":"2014","unstructured":"Trembizki E, Buckley C, Lawrence A, Lahra M, Whiley D: Characterisation of a novel Neisseria gonorrhoeae penicillinase-producing plasmid isolated in Australia in 2012. Antimicrob Agents Chemother. 2014, 58: 4984-4985. 10.1128\/AAC.02993-14.","journal-title":"Antimicrob Agents Chemother"},{"key":"622_CR77","doi-asserted-by":"publisher","first-page":"5225","DOI":"10.1128\/AAC.01295-13","volume":"57","author":"K Shimuta","year":"2013","unstructured":"Shimuta K, Unemo M, Nakayama S, Morita-Ishihara T, Dorin M, Kawahata T, Ohnishi M: Antimicrobial resistance and molecular typing of Neisseria gonorrhoeae isolates in Kyoto and Osaka, Japan, 2010 to 2012: intensified surveillance after identification of the first strain (H041) with high-level ceftriaxone resistance. Antimicrob Agents Chemother. 2013, 57: 5225-5232. 10.1128\/AAC.01295-13.","journal-title":"Antimicrob Agents Chemother"},{"key":"622_CR78","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1128\/AAC.05760-11","volume":"56","author":"M Unemo","year":"2012","unstructured":"Unemo M, Golparian D, Nicholas R, Ohnishi M, Gallay A, Sednaoui P: High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother. 2012, 56: 1273-1280. 10.1128\/AAC.05760-11.","journal-title":"Antimicrob Agents Chemother"},{"key":"622_CR79","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s10096-011-1426-4","volume":"31","author":"SO Hjelmevoll","year":"2012","unstructured":"Hjelmevoll SO, Golparian D, Dedi L, Skutlaberg DH, Haarr E, Christensen A, Jorgensen S, Nilsen OJ, Unemo M, Skogen V: Phenotypic and genotypic properties of Neisseria gonorrhoeae isolates in Norway in 2009: antimicrobial resistance warrants an immediate change in national management guidelines. Eur J Clin Microbiol Infect Dis. 2012, 31: 1181-1186. 10.1007\/s10096-011-1426-4.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"622_CR80","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1136\/sti.2010.045377","volume":"86","author":"D Golparian","year":"2010","unstructured":"Golparian D, Hellmark B, Fredlund H, Unemo M: Emergence, spread and characteristics of Neisseria gonorrhoeae isolates with in vitro decreased susceptibility and resistance to extended-spectrum cephalosporins in Sweden. Sex Transm Infect. 2010, 86: 454-460. 10.1136\/sti.2010.045377.","journal-title":"Sex Transm Infect"},{"key":"622_CR81","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1186\/1471-2334-13-570","volume":"13","author":"S Gose","year":"2013","unstructured":"Gose S, Nguyen D, Lowenberg D, Samuel M, Bauer H, Pandori M: Neisseria gonorrhoeae and extended-spectrum cephalosporins in California: surveillance and molecular detection of mosaic penA. BMC Infect Dis. 2013, 13: 570-10.1186\/1471-2334-13-570.","journal-title":"BMC Infect Dis"},{"key":"622_CR82","doi-asserted-by":"publisher","first-page":"8062","DOI":"10.1021\/bi101167x","volume":"49","author":"J Tomberg","year":"2010","unstructured":"Tomberg J, Unemo M, Davies C, Nicholas RA: Molecular and structural analysis of mosaic variants of penicillin-binding protein 2 conferring decreased susceptibility to expanded-spectrum cephalosporins in Neisseria gonorrhoeae: role of epistatic mutations. Biochemistry. 2010, 49: 8062-8070. 10.1021\/bi101167x.","journal-title":"Biochemistry"},{"key":"622_CR83","doi-asserted-by":"crossref","unstructured":"Update to CDC\u2019s sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections. MMWR Morb Mortal Wkly Rep. 2012, 61: 590-594.","DOI":"10.1016\/j.annemergmed.2012.10.014"},{"key":"622_CR84","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1258\/ijsa.2011.011267","volume":"22","author":"C Bignell","year":"2011","unstructured":"Bignell C, Fitzgerald M: UK national guideline for the management of gonorrhoea in adults, 2011. Int J STD AIDS. 2011, 22: 541-547. 10.1258\/ijsa.2011.011267.","journal-title":"Int J STD AIDS"},{"key":"622_CR85","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1177\/0956462412472837","volume":"24","author":"C Bignell","year":"2013","unstructured":"Bignell C, Unemo M: 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults. Int J STD AIDS. 2013, 24: 85-92. 10.1177\/0956462412472837.","journal-title":"Int J STD AIDS"},{"key":"622_CR86","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/OLQ.0b013e318219cdb5","volume":"38","author":"LF Yuan","year":"2011","unstructured":"Yuan LF, Yin YP, Dai XQ, Pearline RV, Xiang Z, Unemo M, Chen XS: Resistance to azithromycin of Neisseria gonorrhoeae isolates from 2 cities in China. Sex Transm Dis. 2011, 38: 764-768.","journal-title":"Sex Transm Dis"},{"key":"622_CR87","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1071\/SH13077","volume":"10","author":"PJ Read","year":"2013","unstructured":"Read PJ, Limnios EA, McNulty A, Whiley D, Lahra MM: One confirmed and one suspected case of pharyngeal gonorrhoea treatment failure following 500\u00a0mg ceftriaxone in Sydney, Australia. Sex Health. 2013, 10: 460-462. 10.1071\/SH13077.","journal-title":"Sex Health"},{"key":"622_CR88","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1093\/jac\/dkt017","volume":"68","author":"M YC","year":"2013","unstructured":"YC M, Stevens K, Tideman R, Zaia A, Tomita T, Fairley CK, Lahra M, Whiley D, Hogg G: Failure of 500 mg of ceftriaxone to eradicate pharyngeal gonorrhoea, Australia. J Antimicrob Chemother. 2013, 68: 1445-1447. 10.1093\/jac\/dkt017.","journal-title":"J Antimicrob Chemother"},{"key":"622_CR89","doi-asserted-by":"publisher","first-page":"4039","DOI":"10.1128\/AAC.00505-12","volume":"56","author":"T Deguchi","year":"2012","unstructured":"Deguchi T, Yasuda M, Ito S: Management of pharyngeal gonorrhea is crucial to prevent the emergence and spread of antibiotic-resistant Neisseria gonorrhoeae. Antimicrob Agents Chemother. 2012, 56: 4039-4040. 10.1128\/AAC.00505-12. author reply 4041\u20134032","journal-title":"Antimicrob Agents Chemother"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-014-0622-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-014-0622-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-014-0622-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-014-0622-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T06:31:53Z","timestamp":1630564313000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-014-0622-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,27]]},"references-count":89,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["622"],"URL":"https:\/\/doi.org\/10.1186\/s12879-014-0622-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,27]]},"assertion":[{"value":"4 October 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"622"}}